Clinical trials
Recruiting Phase 3 Parkinson Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University College, London | 2 |
| BlueRock Therapeutics | 1 |
| Hoffmann-La Roche | 1 |
| Northwestern University | 1 |
| Radboud University Medical Center | 1 |
| Tanta University | 1 |
| Universita di Verona | 1 |
| University Hospital Tuebingen | 1 |
| University of Alberta | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Parkinson Disease | 10 |
| Agnosia | 1 |
| Basal Ganglia Diseases | 1 |
| Brain Diseases | 1 |
| Brain Neoplasms | 1 |
| Central Nervous System Diseases | 1 |
| Congenital Hyperinsulinism | 1 |
| Deglutition Disorders | 1 |
| Disruptive, Impulse Control, and Conduct Disorders | 1 |
| Lewy Body Disease | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.